LUMOS PHARMA INC - Common Stock (LUMO) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2020 to Q1 2025

Type / Class
Equity / Common Stock
Symbol
LUMO on Nasdaq
Shares outstanding
8,122,625
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of LUMOS PHARMA INC - Common Stock (LUMO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WELLS FARGO & COMPANY/MN 0.8% $251,476 64,981 Wells Fargo & Company 30 Sep 2024

Institutional Holders of LUMOS PHARMA INC - Common Stock (LUMO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q1 0 $0 -$387 0
2024 Q4 100 $387 -$8,080,363 $3.87 1
2024 Q3 2,088,150 $8,080,749 +$437,834 $3.87 28
2024 Q2 2,077,959 $4,820,513 -$285,683 $2.32 35
2024 Q1 2,176,429 $6,137,561 -$538,427 $2.82 35
2023 Q4 2,355,487 $7,480,656 +$2,810,168 $3.18 35
2023 Q3 642,017 $2,118,665 -$225,011 $3.30 4
2023 Q2 2,381,952 $7,858,020 +$530,493 $3.30 33
2023 Q1 2,221,056 $7,364,021 -$645,119 $3.31 33
2022 Q4 2,314,276 $8,352,896 -$532,759 $3.61 31
2022 Q3 2,511,198 $22,225,824 +$1,759,508 $8.85 30
2022 Q2 2,297,776 $17,689,638 -$888,051 $7.70 29
2022 Q1 2,477,740 $23,303,869 -$1,663,831 $9.40 30
2021 Q4 2,695,598 $18,683,286 -$1,244,012 $6.93 30
2021 Q3 2,864,522 $27,238,391 -$3,427,626 $9.51 30
2021 Q2 3,202,560 $32,064,510 +$2,658,821 $10.00 33
2021 Q1 3,077,170 $36,007,642 -$8,143,138 $11.70 33
2020 Q4 3,769,440 $134,565,447 +$4,551,552 $35.71 42
2020 Q3 3,632,133 $50,196,000 +$801,471 $13.82 30
2020 Q2 3,558,915 $58,689,000 +$5,043,673 $16.49 35
2020 Q1 3,276,996 $27,855,000 +$27,728,971 $8.50 37